Gsk Debt-to-Equity Ratio Growth & History (GSK)
Gsk's debt-to-equity ratio was 0.93 for fiscal 2025.
View full Gsk company overviewGsk annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.93 | −0.11 | −10.14% |
| 2024 | 2024-12-31 | 1.04 | −0.18 | −14.69% |
| 2023 | 2023-12-31 | 1.22 | −0.50 | −29.14% |
| 2022 | 2022-12-31 | 1.72 | 0.33 | +24.02% |
| 2021 | 2021-12-31 | 1.39 | −0.12 | −7.73% |
| 2020 | 2020-12-31 | 1.50 | −0.73 | −32.74% |
| 2019 | 2019-12-31 | 2.23 | −3.49 | −61.01% |
| 2018 | 2018-12-31 | 5.72 | — | — |
| 2016 | 2016-12-31 | 12.28 | 11.07 | +916.43% |
| 2015 | 2015-12-31 | 1.21 | — | — |
Gsk quarterly debt-to-equity ratio
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.03 | −0.14 | −11.90% |
| Q1 2026 | 2026-03-31 | 1.07 | — | — |
| Q4 2025 | 2025-12-31 | 0.93 | −0.11 | −10.14% |
| Q3 2025 | 2025-09-30 | 1.10 | — | — |
| Q2 2025 | 2025-06-30 | 1.17 | — | — |
| Q4 2024 | 2024-12-31 | 1.04 | −0.18 | −14.69% |
| Q4 2023 | 2023-12-31 | 1.22 | −0.50 | −29.14% |
| Q4 2022 | 2022-12-31 | 1.72 | 0.33 | +24.02% |
| Q4 2021 | 2021-12-31 | 1.39 | −0.12 | −7.73% |
| Q4 2020 | 2020-12-31 | 1.50 | −0.73 | −32.74% |
| Q4 2019 | 2019-12-31 | 2.23 | −3.49 | −61.01% |
| Q4 2018 · Dec 31 | 2018-12-31 | 5.72 | — | — |
| Q4 2016 | 2016-12-31 | 16.72 | — | — |
Gsk debt-to-equity ratio trends
Over the last five fiscal years, Gsk's debt-to-equity ratio decreased from 1.50 to 0.93, a change of −0.57. The latest reported quarter, Q2 2026, shows 1.03.
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Gsk source filings ↗